KOLT PIQUET: Open Payments
NPI 1780194613 · AMMON, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 73 payments from 24 companies in 2025. Trend: 2023 $678 · 2024 $1,011 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $276 |
| Vanda Pharmaceuticals Inc. | 9 | $264 |
| Phathom Pharmaceuticals, Inc. | 8 | $121 |
| Lilly USA, LLC | 5 | $85 |
| Corcept Therapeutics | 4 | $81 |
| Dexcom, Inc. | 2 | $50 |
| Ionis Pharmaceuticals, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| Boston Scientific Corporation | 2 | $43 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
Products named: FANAPT, VRAYLAR, VOQUEZNA, MOUNJARO, Korlym, QULIPTA, Dexcom G6 Transmitter, TRELEGY ELLIPTA.
Industry payments across ID — which companies pay providers there.
